[Form 4] Enact Holdings, Inc. Insider Trading Activity
Rohit Gupta, President and CEO and a director of Enact Holdings, Inc. (ticker: ACT), reported three separate open-market sales of the issuer's common stock executed on 08/27/2025, 08/28/2025 and 08/29/2025. The filings show dispositions of 11,039, 17,856 and 4,000 shares, respectively, at weighted-average sale prices of $38.18, $37.59 and $37.73 per share. Following the transactions, the reporting person beneficially owned 369,755 shares. The Form 4 is signed by a power of attorney for the reporting person.
- Transparent disclosure of three open-market sales with share counts and weighted-average prices
- Remaining beneficial ownership is clearly reported as 369,755 shares
- Price ranges and willingness to provide trade-level details to the SEC or issuer are explicitly stated
- Insider disposed of 32,895 shares across three days, reducing direct holdings
- No context provided in the filing about the reason for the sales (e.g., planned sales or personal liquidity)
Insights
TL;DR: Routine, disclosed insider sales by the CEO and director totaling 32,895 shares; no derivatives or additional arrangements reported.
The Form 4 documents three separate open-market sales by Rohit Gupta on consecutive dates with clear share counts and weighted-average prices. The filing indicates direct ownership and does not disclose any derivative holdings. From a governance perspective, the disclosure is straightforward and includes explanatory notes about the price ranges, which preserves transparency. The sale reduced beneficial ownership to 369,755 shares; the filing was executed via power of attorney.
TL;DR: Insider sold 32,895 shares across three days at ~$37.6–$38.2, leaving 369,755 shares; no other material transactions disclosed.
The transaction schedule lists three sell transactions: 11,039 shares at a weighted-average $38.18 on 08/27/2025, 17,856 shares at $37.59 on 08/28/2025, and 4,000 shares at $37.73 on 08/29/2025. The filing supplies range-based price explanations and states the remaining beneficial ownership. There are no reported option exercises, grants, or derivative transactions in Table II.